FindTrial
Sign In

Correlation of blood oxidative stress markers and Melasma

Correlation of Plasma Oxidative stress markers with the Severity of Melasma - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055286
Enrollment
81
Registered
2023-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: NIL: NIL

Sponsors

FATHER MULLER RESEARCH CENTRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age 18years and above. 2.Patients of all gender. 3.Patients diagnosed with melasma clinically with MASI score indicating severity.

Exclusion criteria

Exclusion criteria: 1.Patients who are pregnant, active smokers, on hormonal therapy, consumption of antioxidant supplements. 2.Patients with vitiligo, psoriasis, facial melanosis excluding melasma, other causes of skin pigmentation like acanthosis nigricans, sun tan, hair dye etc 3.Patients with endocrine and chronic systemic diseases like diabetes mellitus, heart failure, systemic lupus, etc. 4.Patients on drugs affecting antioxidant levels like hydroxychloroquine,immunosuppresive drugs

Design outcomes

Primary

MeasureTime frame
Plasma glutathione, Total anti oxidant capacity and malondialdehyde of patients with MelasmaTimepoint: 0weeks or at presentation—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Jiby V Benny

FATHER MULLER MEDICAL COLLEGE HOSPITAL

rochelle@fathermuller.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026